Electronic nicotine delivery systems ("E-cigarettes"): Review of safety and smoking cessation efficacy

Otolaryngology - Head and Neck Surgery (United States)

Volumn 151, Issue 3, 2014, Pages 381-393

  Harrell, Paul Truman ^a   Simmons, Vani Nath ^a   Correa, John Bernard ^a   Padhya, Tapan Ashvin ^b   Brandon, Thomas Henry ^a  

^a H LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE   (United States)

^b UNIVERSITY OF SOUTH FLORIDA   (United States)

Author keywords

carcinogens; e cigarettes; electronic nicotine delivery systems; nicotine; personal vaporizers; smoking; toxicity; vapers; vaping

Indexed keywords

ELECTRONIC CIGARETTE; NICOTINE;

CYTOTOXICITY; DEVICE SAFETY; HUMAN; REVIEW; SMOKING; SMOKING CESSATION; VAPORIZER;

CARCINOGENS; E-CIGARETTES; ELECTRONIC NICOTINE DELIVERY SYSTEMS; NICOTINE; PERSONAL VAPORIZERS; SMOKING; TOXICITY; VAPERS; VAPING;

CLINICAL TRIALS AS TOPIC; DRUG DELIVERY SYSTEMS; ELECTRONICS; FEMALE; HUMANS; MALE; NEBULIZERS AND VAPORIZERS; SMOKING; SMOKING CESSATION; TOBACCO USE CESSATION PRODUCTS; TREATMENT OUTCOME;

EID: 84908301788     PISSN: 01945998     EISSN: 10976817     Source Type: Journal    
DOI: 10.1177/0194599814536847     Document Type: Review

References (116)

1. The Health Consequences of Smoking 50 Years of Progress: A Report of the Surgeon General. Atlanta, GA: US Department of Health and Human Services, Centers for Disease Control and Prevention, National Center for Chronic Disease Prevention and Health Promotion, Office on Smoking and Health ; 2014 :
2. Blot WJ, McLaughlin JK, Winn DM, et al. Smoking and drinking in relation to oral and pharyngeal cancer. Cancer Res. 1988 ; 48: 3282-3287
3. Hashibe M, Brennan P, Chuang SC, et al. Interaction between tobacco and alcohol use and the risk of head and neck cancer: pooled analysis in the International Head and Neck Cancer Epidemiology Consortium. Cancer Epidemiol Biomarkers Prev. 2009 ; 18: 541-550
4. Doll R, Peto R, Boreham J, Sutherland I. Mortality in relation to smoking: 50 years' observations on male British doctors. BMJ. 2004 1519 ; 328 :
5. Duffy SA, Ronis DL, McLean S, et al. Pretreatment health behaviors predict survival among patients with head and neck squamous cell carcinoma. J Clin Oncol. 2009 ; 27: 1969-1975
6. Browman GP, Wong G, Hodson I, et al. Influence of cigarette smoking on the efficacy of radiation therapy in head and neck cancer. N Engl J Med. 1993 ; 328: 159-163 (Pubitemid 23021501)
7. Kawahara M, Ushijima S, Kamimori T, et al. Second primary tumours in more than 2-year disease-free survivors of small-cell lung cancer in Japan: the role of smoking cessation. Br J Cancer. 1998 ; 78: 409-412 (Pubitemid 28336431)
8. Stevens MH, Gardner JW, Parkin JL, Johnson LP. Head and neck cancer survival and life-style change. Arch Otolaryngol. 1983 ; 109: 746-749 (Pubitemid 14228206)
9. Gritz ER, Carr CR, Rapkin DA, Chang C, Beumer J, Ward PH. A smoking cessation intervention for head and neck cancer patients: trial design, patient accrual, and characteristics. Cancer Epidemiol Biomarkers Prev. 1991 ; 1: 67-73
10. Ostroff JS, Jacobsen PB, Moadel AB, et al. Prevalence and predictors of continued tobacco use after treatment of patients with head and neck cancer. Cancer. 1995 ; 75: 569-576
11. Pauly J, Li Q, Barry MB. Tobacco-free electronic cigarettes and cigars deliver nicotine and generate concern. Tob Control. 2007 ; 16: 357
12. Zhu SH, Gamst A, Lee M, Cummins S, Yin L, Zoref L. The use and perception of electronic cigarettes and snus among the U.S. population. PLoS One. 2013 ; 8: e79332
13. Foulds J, Veldheer S, Berg A. Electronic cigarettes (e-cigs): views of aficionados and clinical/public health perspectives. Int J Clin Pract. 2011 ; 65: 1037-1042
14. Saitta D, Ferro GA, Polosa R. Achieving appropriate regulations for electronic cigarettes. Ther Adv Chronic Dis. 2014 ; 5 (2). 50-61
15. King BA, Alam S, Promoff G, Arrazola R, Dube SR. Awareness and ever use of electronic cigarettes among U.S. adults, 2010-2011. Nicotine Tob Res. 2013 ; 15: 1623-1627
16. Etter JF, Bullen C. Electronic cigarette: users profile, utilization, satisfaction and perceived efficacy. Addiction. 2011 ; 106: 2017-2028
17. Etter JF. Electronic cigarettes: a survey of users. BMC Public Health. 2010 ; 10: 231
18. Goniewicz ML, Lingas EO, Hajek P. Patterns of electronic cigarette use and user beliefs about their safety and benefits: an Internet survey. Drug Alcohol Rev. 2013 ; 32: 133-140
19. GardinerP. E-cigarettes: the vapor this time?http://www.trdrp.org/docs/E- Cigarettes%20The%20Vapor%20This%20Time.pdf. 2013.
20. Kuschner WG, Reddy S, Mehrotra N, Paintal HS. Electronic cigarettes and thirdhand tobacco smoke: two emerging health care challenges for the primary care provider. Int J Gen Med. 2011 ; 4: 115-120
21. Pepper JK, Brewer NT. Electronic nicotine delivery system (electronic cigarette) awareness, use, reactions and beliefs: a systematic review. Tob Control. 2013 ;:
22. Trehy ML, Ye W, Hadwiger ME, et al. Analysis of electronic cigarette cartridges, refill solutions, and smoke for nicotine and nicotine related impurities. J Liq Chromatogr Relat Technol. 2011 ; 34: 1442-1458
23. Cameron JM, Howell DN, White JR, Andrenyak DM, Layton ME, Roll JM. Variable and potentially fatal amounts of nicotine in e-cigarette nicotine solutions. Tob Control. 2014 ; 23: 77-8
24. Cheah NP, Chong NW, Tan J, Morsed FA, Yee SK. Electronic nicotine delivery systems: regulatory and safety challenges: Singapore perspective. Tob Control. 2014 ; 23: 119-125
25. Odum LE, O'Dell KA, Schepers JS. Electronic cigarettes: do they have a role in smoking cessation?. J Pharm Pract. 2012 ; 25: 611-614
26. Flouris AD, Oikonomou DN. Electronic cigarettes: miracle or menace?. BMJ. 2010 ; 340: c311
27. Farsalinos KE, Romagna G, Tsiapras D, Kyrzopoulos S, Voudris V. Evaluating nicotine levels selection and patterns of electronic cigarette use in a group of "vapers" who had achieved complete substitution of smoking. Subst Abuse. 2013 ; 7: 139-146
28. Benowitz NL, Goniewicz ML. The regulatory challenge of electronic cigarettes. JAMA. 2013 ; 310: 685-686
29. Cardinale A, Nastrucci C, Cesario A, Russo P. Nicotine: specific role in angiogenesis, proliferation and apoptosis. Crit Rev Toxicol. 2012 ; 42: 68-89
30. Murray RP, Connett JE, Zapawa LM. Does nicotine replacement therapy cause cancer? Evidence from the Lung Health Study. Nicotine Tob Res. 2009 ; 11: 1076-1082
31. Stepanov I, Carmella SG, Briggs A, et al. Presence of the carcinogen N'-nitrosonornicotine in the urine of some users of oral nicotine replacement therapy products. Cancer Res. 2009 ; 69: 8236-8240
32. Stepanov I, Carmella SG, Han S, et al. Evidence for endogenous formation of N'-nitrosonornicotine in some long-term nicotine patch users. Nicotine Tob Res. 2009 ; 11: 99-105
33. Report on Carcinogens. 12 th ed.Washington, DC: U.S. Department of Health and Human Services Public Health Service National Toxicology Program; 2011. Washington, DC: U.S. Department of Health and Human Services Public Health Service National Toxicology Program ; 2011 :
34. Etter JF, Zather E, Svensson S. Analysis of refill liquids for electronic cigarettes. Addiction. 2013 ; 108: 1671-1679
35. Kirschner RI, Gerona R, Jacobitz KL. Nicotine content of liquid for electronic cigarettes. Clin Toxicol. 2013 ; 51: 684-684
36. Eissenberg T. Electronic nicotine delivery devices: ineffective nicotine delivery and craving suppression after acute administration. Tob Control. 2010 ; 19: 87-88
37. Vansickel AR, Cobb CO, Weaver MF, Eissenberg TE. A clinical laboratory model for evaluating the acute effects of electronic "cigarettes": nicotine delivery profile and cardiovascular and subjective effects. Cancer Epidemiol Biomarkers Prev. 2010 ; 19: 1945-1953
38. Trtchounian A, Williams M, Talbot P. Conventional and electronic cigarettes (e-cigarettes) have different smoking characteristics. Nicotine Tob Res. 2010 ; 12: 905-912
39. Williams M, Talbot P. Variability among electronic cigarettes in the pressure drop, airflow rate, and aerosol production. Nicotine Tob Res. 2011 ; 13: 1276-1283
40. Goniewicz ML, Kuma T, Gawron M, Knysak J, Kosmider L. Nicotine levels in electronic cigarettes. Nicotine Tob Res. 2013 ; 15: 158-166
41. Strasser AA, Lerman C, Sanborn PM, Pickworth WB, Feldman EA. New lower nicotine cigarettes can produce compensatory smoking and increased carbon monoxide exposure. Drug Alcohol Depend. 2007 ; 86: 294-300 (Pubitemid 44821611)
42. Vansickel AR, Eissenberg T. Electronic cigarettes: effective nicotine delivery after acute administration. Nicotine Tob Res. 2013 ; 15: 267-270
43. Etter JF, Bullen C. Saliva cotinine levels in users of electronic cigarettes. Eur Respir J. 2011 ; 38: 1219-1220
44. Flouris AD, Chorti MS, Poulianiti KP, et al. Acute impact of active and passive electronic cigarette smoking on serum cotinine and lung function. Inhal Toxicol. 2013 ; 25: 91-101
45. Farsalinos KE, Romagna G, Tsiapras D, Kyrzopoulos S, Voudris V. Evaluation of electronic cigarette use (vaping) topography and estimation of liquid consumption: implications for research protocol standards definition and for public health authorities' regulation. Int J Environ Res Public Health. 2013 ; 10: 2500-2514
46. Goniewicz ML, Knysak J, Gawron M, et al. Levels of selected carcinogens and toxicants in vapour from electronic cigarettes. Tob Control. 2014 ; 23: 133-139
47. Ohta K, Uchiyama S, Inaba Y, Nakagome H, Kunugita N. Determination of carbonyl compounds generated from the electronic cigarette using coupled silica cartridges impregnated with hydroquinone and 2,4-dinitrophenylhydrazine. Bunseki Kagaku. 2011 ; 60: 791-797
48. Pellegrino RM, Tinghino B, Mangiaracina G, et al. Electronic cigarettes: an evaluation of exposure to chemicals and fine particulate matter (PM). Ann Ig. 2012 ; 24: 279-288
49. Hadwiger ME, Trehy ML, Ye W, Moore T, Allgire J, Westenberger B. Identification of amino-tadalafil and rimonabant in electronic cigarette products using high pressure liquid chromatography with diode array and tandem mass spectrometric detection. J Chromatogr A. 2010 ; 1217: 7547-7555
50. Kim HJ, Shin HS. Determination of tobacco-specific nitrosamines in replacement liquids of electronic cigarettes by liquid chromatography-tandem mass spectrometry. J Chromatogr A. 2013 ; 1291: 48-55
51. Ayala G, Smith CA. Chemical analysis of electronic cigarette smoke. Abstr Papers of the ACS. 2010 ;: 240
52. Williams M, Villarreal A, Bozhilov K, Lin S, Talbot P. Metal and silicate particles including nanoparticles are present in electronic cigarette cartomizer fluid and aerosol. PLoS One. 2013 ; 8: e57987
53. Bahl V, Lin S, Xu N, Davis B, Wang YH, Talbot P. Comparison of electronic cigarette refill fluid cytotoxicity using embryonic and adult models. Reprod Toxicol. 2012 ; 34: 529-537
54. Romagna G, Allifranchini E, Bocchietto E, Todeschi S, Esposito M, Farsalinos KE. Cytotoxicity evaluation of electronic cigarette vapor extract on cultured mammalian fibroblasts (ClearStream-LIFE): comparison with tobacco cigarette smoke extract. Inhal Toxicol. 2013 ; 25: 354-361
55. Farsalinos KE, Romagna G, Allifranchini E, et al. Comparison of the cytotoxic potential of cigarette smoke and electronic cigarette vapour extract on cultured myocardial cells. Int J Environ Res Public Health. 2013 ; 10: 5146-5162
56. Park SJ, Walser TC, Perdomo C, et al. Abstract B16: The effect of e-cigarette exposure on airway epithelial cell gene expression and transformation. Clin Cancer Res. 2014 ; 20: B16
57. Van Staden SR, Groenewald M, Engelbrecht R, Becker PJ, Hazelhurst LT. Carboxyhaemoglobin levels, health and lifestyle perceptions in smokers converting from tobacco cigarettes to electronic cigarettes. S Afr Med J. 2013 ; 103: 865-868
58. Farsalinos KE, Romagna G. Chronic idiopathic neutrophilia in a smoker, relieved after smoking cessation with the use of electronic cigarette: a case report. Clin Med Insights Case Rep. 2013 ; 6: 15
59. Vardavas CI, Anagnostopoulos N, Kougias M, Evangelopoulou V, Connolly GN, Behrakis PK. Short-term pulmonary effects of using an electronic cigarette: impact on respiratory flow resistance, impedance, and exhaled nitric oxide. Chest. 2012 ; 141: 1400-1406
60. Flouris AD, Poulianiti KP, Chorti MS, et al. Acute effects of electronic and tobacco cigarette smoking on complete blood count. Food Chem Toxicol. 2012 ; 50: 3600-3603
61. Kouretas D, Poulianiti K, Chorti M, et al. Effects of electronic cigarette and tobacco cigarette smoking on complete blood count. Toxicology Letters. 2012 ; 211: S64 - S64
62. Tzatzarakis MN, Tsitoglou KI, Chorti MS, et al. Acute and short term impact of active and passive tobacco and electronic cigarette smoking on inflammatory markers. Toxicology Letters. 2013 ; 221: S86 - S86
63. Czogala J, Cholewinski M, Kutek A, Zielinska-Danch W. [Evaluation of changes in hemodynamic parameters after the use of electronic nicotine delivery systems among regular cigarette smokers]. Przegl Lek. 2012 ; 69: 841-845
64. Farsalinos K, Tsiapras D, Kyrzopoulos S, et al. Acute effects of using an electronic nicotine-delivery device (e-cigarette) on myocardial function: comparison with the effects of regular cigarettes. European Heart J. 2012 ; 33: 203
65. Chen I-L. FDA summary of adverse events on electronic cigarettes. Nicotine Tob Res. 2013 ; 15: 615-616
66. Hua M, Alfi M, Talbot P. Health-related effects reported by electronic cigarette users in online forums. J Med Internet Res. 2013 ; 15: e59
67. Monroy AE, Hommel E, Smith ST, Raji M. Paroxysmal atrial fibrillation following electronic cigarette use in an elderly woman. Clin Geriatrics. 2012 ; 20: 28-32
68. McCauley L, Markin C, Hosmer D. An unexpected consequence of electronic cigarette use. Chest. 2012 ; 141: 1110-1113
69. Ordonez J, Forrester MB, Kleinschmidt K. Electronic cigarette exposures reported to poison centers. Clin Toxicol. 2013 ; 51: 685-685
70. Cantrell L. E-cigarette exposures-nothing to get choked up about. Clin Toxicol. 2013 ; 51: 684-685
71. Waldman W, Sein Anand J. [Cardiac arrest during intoxication with nicotine-a case report and a review of literature]. Przegl Lek. 2012 ; 69: 606
72. Christensen LB, van't Veen T, Bang J. Three cases of attempted suicide by ingestion of nicotine liquid used in e-cigarettes. Clin Toxicol. 2013 ; 51: 290
73. Thornton S, Oller L, Sawyer T. Fatal intravenous injection of electronic cigarette "eLiquid" solution. Clin Toxicol. 2013 ; 51: 683
74. McAuley TR, Hopke PK, Zhao J, Babaian S. Comparison of the effects of e-cigarette vapor and cigarette smoke on indoor air quality. Inhal Toxicol. 2012 ; 24: 850-857
75. Ingebrethsen BJ, Cole SK, Alderman SL. Electronic cigarette aerosol particle size distribution measurements. Inhal Toxicol. 2012 ; 24: 976-984
76. Schripp T, Markewitz D, Uhde E, Salthammer T. Does e-cigarette consumption cause passive vaping?. Indoor Air. 2013 ; 23: 25-31
77. Zhang Y, Sumner W, Chen DR. In vitro particle size distributions in electronic and conventional cigarette aerosols suggest comparable deposition patterns. Nicotine Tob Res. 2013 ; 15: 501-508
78. Fuoco FC, Buonanno G, Stabile L, Vigo P. Influential parameters on particle concentration and size distribution in the mainstream of e-cigarettes. Environ Pollut. 2014 ; 184: 523-529
79. Caponnetto P, Polosa R, Russo C, Leotta C, Campagna D. Successful smoking cessation with electronic cigarettes in smokers with a documented history of recurring relapses: a case series. J Med Case Rep. 2011 ; 5: 585
80. Barbeau AM, Burda J, Siegel M. Perceived efficacy of e-cigarettes versus nicotine replacement therapy among successful e-cigarette users: a qualitative approach. Addict Sci Clin Pract. 2013 ; 8: 5
81. McQueen A, Tower S, Sumner W. Interviews with "vapers": implications for future research with electronic cigarettes. Nicotine Tob Res. 2011 ; 13: 860-867
82. Caponnetto P, Polosa R, Auditore R, Russo C, Campagna D. Smoking cessation with e-cigarettes in smokers with a documented history of depression and recurring relapses. Int J Clin Med. 2011 ; 2: 281-284
83. Adkison SE, O'Connor RJ, Bansal-Travers M, et al. Electronic nicotine delivery systems: international tobacco control four-country survey. Am J Prev Med. 2013 ; 44: 207-215
84. Pokhrel P, Fagan P, Little MA, Kawamoto CT, Herzog TA. Smokers who try e-cigarettes to quit smoking: findings from a multiethnic study in Hawaii. Am J Public Health. 2013 ; 103: e57-62
85. Pisinger C, Godtfredsen NS. Is there a health benefit of reduced tobacco consumption? A systematic review. Nicotine Tob Res. 2007 ; 9: 631-646 (Pubitemid 46930313)
86. Jena PK, Kishore J, Jahnavi G. Correlates of digit bias in self-reporting of cigarette per day (CPD) frequency: results from Global Adult Tobacco Survey (GATS), India and its implications. Asian Pac J Cancer Prev. 2013 ; 14: 3865-3869
87. Klesges RC, Debon M, Ray JW. Are self-reports of smoking rate biased? Evidence from the Second National Health and Nutrition Examination Survey. J Clin Epidemiol. 1995 ; 48: 1225-1233
88. Dawkins L, Turner J, Roberts A, Soar K. "Vaping" profiles and preferences: an online survey of electronic cigarette users. Addiction. 2013 ; 108: 1115-1125
89. Siegel MB, Tanwar KL, Wood KS. Electronic cigarettes as a smoking-cessation tool: results from an online survey. Am J Prev Med. 2011 ; 40: 472-475
90. Popova L, Ling PM. Alternative tobacco product use and smoking cessation: a national study. Am J Public Health. 2013: e1 - e8
91. Vickerman KA, Carpenter KM, Altman T, Nash CM, Zbikowski SM. Use of electronic eigarettes among state tobacco cessation quitline callers. Nicotine Tob Res. 2013 ; 15: 1787-1791
92. Wagener TL, Meier E, Hale JJ, et al. Pilot investigation of changes in readiness and confidence to quit smoking after e-cigarette experimentation and 1 week of use. Nicotine Tob Res. 2014 ; 16: 108-114
93. Polosa R, Caponnetto P, Morjaria JB, Papale G, Campagna D, Russo C. Effect of an electronic nicotine delivery device (e-cigarette) on smoking reduction and cessation: a prospective 6-month pilot study. BMC Public Health. 2011 ; 11: 786
94. PolosaRMorjariaJBCaponnettoP. Effectiveness and tolerability of electronic cigarette in real-life: a 24-month prospective ul 20. [Epub ahead of print]
95. Caponnetto P, Campagna D, Cibella F, et al. efficiency and safety of an electronic cigarette (ECLAT) as tobacco cigarettes substitute: a prospective 12-month randomized control design study. PLoS One. 2013 ; 8: e66317
96. Caponnetto P, Auditore R, Russo C, Cappello GC, Polosa R. Impact of an electronic cigarette on smoking reduction and cessation in schizophrenic smokers: a prospective 12-month pilot study. Int J Environ Res Public Health. 2013 ; 10: 446-461
97. Bullen C, Williman J, Howe C, et al. Study protocol for a randomised controlled trial of electronic cigarettes versus nicotine patch for smoking cessation. BMC Public Health. 2013 ; 13: 210
98. Bullen C, Howe C, Laugesen M, et al. Electronic cigarettes for smoking cessation: a randomised controlled trial. Lancet. 2013 ; 382: 1629-1637
99. de Bruin-Visser JC, Ackerstaff AH, Rehorst H, Hilgers FJM. Integration of a smoking cessation program in the treatment protocol for patients with head and neck and lung cancer. Eur Arch ORL. 2012 ; 269: 659-665
100. Henningfield JE, Zaatari GS. Electronic nicotine delivery systems: emerging science foundation for policy. Tob Control. 2010 ; 19: 89-90
101. Etter JF, Bullen C, Flouris AD, Laugesen M, Eissenberg T. Electronic nicotine delivery systems: a research agenda. Tob Control. 2011 ; 20: 243-248
102. Gritz ER, Fingeret MC, Vidrine DJ, Lazev AB, Mehta NV, Reece GP. Successes and failures of the teachable moment: smoking cessation in cancer patients. Cancer. 2006 ; 106: 17-27 (Pubitemid 43032545)
103. Smith SS, McCarthy DE, Japuntich SJ, et al. Comparative effectiveness of 5 smoking cessation pharmacotherapies in primary care clinics. Arch Intern Med. 2009 ; 169: 2148-2155
104. Fiore MC, Jaen CR, Baker TB, et al Treating Tobacco Use and Dependence: 2008 Update. Rockville, MD: US Department of Health and Human Services, Public Health Service ; 2008 :
105. Quinn VP, Hollis JF, Smith KS, et al. Effectiveness of the 5-As tobacco cessation treatments in nine HMOs. J Gen Intern Med. 2009 ; 24: 149-154
106. Tong EK, Strouse R, Hall J, Kovac M, Schroeder SA. National survey of U.S. health professionals' smoking prevalence, cessation practices, and beliefs. Nicotine Tob Res. 2010 ; 12: 724-733
107. Emmons KM, Sprunck-Harrild K, Puleo E, de Moor J. Provider advice about smoking cessation and pharmacotherapy among cancer survivors who smoke: practice guidelines are not translating. Transl Behav Med. 2013 ; 3: 211-217
108. Warren GW, Marshall JR, Cummings KM, et al. Addressing tobacco use in patients with cancer: a survey of american society of clinical oncology members. J Oncol Pract. 2013 ; 9: 258-262
109. Toll BA, Brandon TH, Gritz ER, et al. Assessing tobacco use by cancer patients and facilitating cessation: an American Association for Cancer Research policy statement. Clin Cancer Res. 2013 ; 19: 1941-1948
110. Rosenthal.A.1468. Memorandum in support. 2010. http://acscan.org/ovc- images/file/action/states/ny/A1468-Memo.pdf.
111. GlynnTJ. Electronic cigarettes - boon, bane, blessing or boondoggle?http://www.cancer.org/cancer/news/expertvoices/post/2011/05/03/ electronic-cigarettes-e28093-boon-bane-blessing-or-boondoggle.aspx. Accessed March 28, 2014.
112. American Cancer Society. http://www.cancer.org/cancer/cancercauses/ tobaccocancer/questionsaboutsmokingtobaccoandhealth/questions-about-smoking- tobacco-and-health-e-cigarettes. Accessed March 28, 2014.
113. American Lung Association. http://www.lung.org/stop-smoking/tobacco- control-advocacy/federal/e-cigarettes.html. Accessed March 28, 2014.
114. Cummings KM, Dresler CM, Field JK, et al. E-cigarettes and cancer patients. J Thorac Oncol. 2014 ; 9: 438-441
115. Rose JE, Turner JE, Murugesan T, Behm FM, Laugesen M. Pulmonary delivery of nicotine pyruvate: sensory and pharmacokinetic characteristics. Exp Clin Psychopharmacol. 2010 ; 18: 385-394
116. Lunell E, Molander L, Ekberg K, Wahren J. Site of nicotine absorption from a vapour inhaler-comparison with cigarette smoking. Eur J Clin Pharmacol. 2000 ; 55: 737-741 (Pubitemid 30077569)